Rigel Pharmaceuticals RIGL Cash ratio
Cash ratio at other companies
Other financials
Where this comes from
Calculated from Rigel Pharmaceuticals’s reported figures.
Based on the most recent quarter.
The official record: Rigel Pharmaceuticals’s 10-Q, filed May 5, 2026, on SEC EDGAR. View the filing →
Ask your AI about Rigel Pharmaceuticals's cash ratio.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Rigel Pharmaceuticals's cash ratio?
- Rigel Pharmaceuticals (RIGL) reported cash ratio of 0.3× in Q1 2026.
- How has Rigel Pharmaceuticals's cash ratio changed year-over-year?
- Rigel Pharmaceuticals's cash ratio decreased by 60.2% year-over-year, from 0.7× to 0.3×.
- What is the long-term trend for Rigel Pharmaceuticals's cash ratio?
- Over 5 years (2020 to 2025), Rigel Pharmaceuticals's cash ratio has grown at a -11.2% compound annual growth rate (CAGR), from 0.7× to 0.4×.
- What does cash ratio mean?
- Cash and equivalents divided by current liabilities at the quarter end. The most conservative liquidity measure — what the company could pay immediately with cash on hand.